Chao Liu

机构：Changsha University, Kunming Medical University, Jinan Stomatological Hospital, Jining Medical University · ORCID：0000-0002-3807-9901

发表论文 396 篇 · 总被引 8816 次 · h-index 45

代表论文

• Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 46)
• Role of CD4+ T cells in cancer immunity: a single-cell sequencing exploration of tumor microenvironment (2025 · Journal of Translational Medicine · 被引 21)
• Cancer-associated fibroblasts in clear cell renal cell carcinoma: functional heterogeneity, tumor microenvironment crosstalk, and therapeutic opportunities (2025 · Frontiers in Immunology · 被引 16)
• Immunomodulatory roles of butyrate in asthma: mechanisms and therapeutic potentials (2025 · Frontiers in Immunology · 被引 12)
• Protocatechuic Acid Reduces Liver Fatty Acid Uptake in HFD‐Fed Mice Associated With the Inhibition of DHHC5‐Mediated CD36 Palmitoylation (2025 · Molecular Nutrition & Food Research · 被引 11)
• Heterogeneity of diabetes and disease progression with a tree-like representation: findings from the China Cardiometabolic Disease and Cancer Cohort (4C) study (2025 · Diabetologia · 被引 9)